Two Years of Anti-Androgen Treatment Increases Other-Cause Mortality in Men Receiving Early Salvage Radiotherapy: A Secondary Analysis of the NRG Oncology/RTOG 9601 Randomized Phase III Trial.
Saved in:
| Title: | Two Years of Anti-Androgen Treatment Increases Other-Cause Mortality in Men Receiving Early Salvage Radiotherapy: A Secondary Analysis of the NRG Oncology/RTOG 9601 Randomized Phase III Trial. |
|---|---|
| Authors: | Spratt, D.E.1 (AUTHOR), Dess, R.T.1 (AUTHOR), Efstathiou, J.A.2 (AUTHOR), Zietman, A.L.3 (AUTHOR), Wallington, D.G.4 (AUTHOR), Jairath, N.K.5 (AUTHOR), Jackson, W.C.1 (AUTHOR), Den, R.B.6,7 (AUTHOR), Stish, B.J.8 (AUTHOR), Morgan, T.M.9 (AUTHOR), Dignam, J.J.10 (AUTHOR), Pisansky, T.M.8 (AUTHOR), Rosenthal, S.A.11 (AUTHOR), Michalski, J.M.12 (AUTHOR), Sartor, O.13 (AUTHOR), Feng, F.Y.14 (AUTHOR), Schipper, M.15 (AUTHOR), Sandler, H.M.16 (AUTHOR), Sun, Y.17 (AUTHOR), Shipley, W.U.2 (AUTHOR) |
| Source: | International Journal of Radiation Oncology, Biology, Physics. Nov2019, Vol. 105 Issue 3, p680-680. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 03603016 |
|---|---|
| DOI: | 10.1016/j.ijrobp.2019.08.029 |
